ABOUT THE VIRTUAL SERIES
3-Part Series
Since the MATE-ACT took effect in June 2023, health care clinicians have been encouraged to incorporate Buprenorphine into clinical practice for persons with Opioid Use Disorders and/or Chronic Pain. In these 3 sessions, we will explain why and how buprenorphine use as a continuous medication is on the climb in many clinical and hospital settings and explore future uses currently being evaluated in clinical research.
Participation is free. Pre-registration is required.
SESSION DATES
MARCH 25 | NOON -1PM CST
The Role of Buprenorphine in the Clinical
Setting: MOUD and Chronic Pain – Part 1
APRIL 29 | NOON-1PM CST
The Role of Buprenorphine in the Clinical Setting: MOUD and Chronic Pain – Part 2
MAY 27 | NOON-1PM CST
The Role of Buprenorphine in the Clinical Setting: Latest research on buprenorphine use in other medical conditions
Click the “register” buttons above or scan the QR code.